Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Lung/Thoracic Oncology

A randomised phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in advanced squamous cell lung carcinoma (C-TONG1002)

European Journal of Cancer | Feb 26, 2019 Lung/Thoracic Oncology

Impact of estrogen monotherapy on survival in women with stage III-IV non-small cell lung cancer

Lung Cancer | Feb 25, 2019 Lung/Thoracic Oncology

Cancer statistics, 2019

CA: A Cancer Journal for Clinicians | Feb 23, 2019 Lung/Thoracic Oncology

A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma

Journal of Translational Medicine | Feb 23, 2019 Lung/Thoracic Oncology

Alopecia neoplastica as a sign of visceral malignancies: A systematic review

Journal of the European Academy of Dermatology and Venereology | Feb 22, 2019 Lung/Thoracic Oncology

Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer

Cancer Medicine | Feb 22, 2019 Lung/Thoracic Oncology

Evaluation of second solid cancers after hematopoietic stem cell transplantation in European patients

JAMA | Feb 21, 2019 Lung/Thoracic Oncology

Triple marker composed of p16, CD56, and TTF1 shows higher sensitivity than INSM1 for diagnosis of pulmonary small cell carcinoma: Proposal for a rational immunohistochemical algorithm for diagnosis of small cell carcinoma in small biopsy and cytology specimens

Human Pathology | Feb 21, 2019 Lung/Thoracic Oncology

Nivolumab-refractory patients with advanced non-small-cell lung cancer

Lung Cancer | Feb 20, 2019 Lung/Thoracic Oncology

Stereotactic ablative radiotherapy vs standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): A phase 3, open-label, randomised controlled trial

The Lancet Oncology | Feb 18, 2019 Lung/Thoracic Oncology

« Prev 1 … 99 100 101 102 103 … 149 Next »

A randomised phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in advanced squamous cell lung carcinoma (C-TONG1002)

Impact of estrogen monotherapy on survival in women with stage III-IV non-small cell lung cancer

Cancer statistics, 2019

A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma

Alopecia neoplastica as a sign of visceral malignancies: A systematic review

Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer

Evaluation of second solid cancers after hematopoietic stem cell transplantation in European patients

Triple marker composed of p16, CD56, and TTF1 shows higher sensitivity than INSM1 for diagnosis of pulmonary small cell carcinoma: Proposal for a rational immunohistochemical algorithm for diagnosis of small cell carcinoma in small biopsy and cytology specimens

Nivolumab-refractory patients with advanced non-small-cell lung cancer

Stereotactic ablative radiotherapy vs standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): A phase 3, open-label, randomised controlled trial

BRI or BMI: What is More Efficient?

Awareness for COPD: MCQ challenge

Gut Health Disorders and its Management

How 2 Common Sleep Habits Increase Your Risk of Death

The Role of Exercise and Movement Therapy in Enhancing Recovery from Chronic Conditions

A randomised phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in advanced squamous cell lung carcinoma (C-TONG1002)

Impact of estrogen monotherapy on survival in women with stage III-IV non-small cell lung cancer

Cancer statistics, 2019

A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma

Alopecia neoplastica as a sign of visceral malignancies: A systematic review

Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer

Evaluation of second solid cancers after hematopoietic stem cell transplantation in European patients

Triple marker composed of p16, CD56, and TTF1 shows higher sensitivity than INSM1 for diagnosis of pulmonary small cell carcinoma: Proposal for a rational immunohistochemical algorithm for diagnosis of small cell carcinoma in small biopsy and cytology specimens

Nivolumab-refractory patients with advanced non-small-cell lung cancer

Stereotactic ablative radiotherapy vs standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): A phase 3, open-label, randomised controlled trial

BRI or BMI: What is More Efficient?

Awareness for COPD: MCQ challenge

Gut Health Disorders and its Management

How 2 Common Sleep Habits Increase Your Risk of Death

The Role of Exercise and Movement Therapy in Enhancing Recovery from Chronic Conditions

Select Specialty

Select Topic